Vitals Spotlight - We Give the Doctor an Exam

(realself.com)

Online beauty blog TruthinAging.com has noted that FDA has warned Allergan, the makers of Botox, that the website for its eyelash growth product, Latisse, is misleading because it avoids or downplays risks associated with the product.

The FDA said that Latisse, a prescription only product either doesn’t mention potential side effects like permanent changes in iris and eyelid pigmentation, or presents them in small text that is much less prominent than statements about the product’s effectiveness. The product web site leaves out information that is included in Latisse packaging.

Based on collective experience, people with crystal clear blue eyes don’t develop the iris pigmentation, the people who are susceptible to it are individuals with brown eyes or hazel eyes or greenish-blue eyes. But the overall risk is less than 1 percent and that’s with the medication going directly into the eye.

says Dr. Arielle Kauvar, clinical associate professor of dermatology at New York University School of Medicine.  According to Vitals.com, Dr. Kauvar completed his medical degree at Harvard University School of Medicine and is one of Castle Connolly’s America’s Top Doctors in the New York Metro area.

Marta at TruthinAging.com notes:

I just checked out the Latisse site and it seems to have responded rapidly to the FDA’s complaints. There is a clearly positioned ‘about safety‘ tab on the home page and the potential side effects, including permanent change of eye color, are set out in full.

CONSULT DR. ARIELLE KAUVAR BEFORE PURCHASING

Tags: allergan, botox, Dr. Arielle Kauvar, Dr. Nancy Snyderman, eye lashes, FDA, latisse, New York University School of Medicine, the makers of Botox, truthinaging, TruthinAging.com

This entry was posted on Friday, October 16th, 2009 at 8:53 am and is filed under Medical Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.